NFKBIA and nasopharyngeal carcinoma: High-frequency mutations in CYLD (10.5%, 11/105), TRAF3 (8.6%, 9/105), and NFKBIA (6.7%, 7/105) lead to constitutive activation of the nonclassical NF-κB pathway in NPC [11].